International Journal of Hypertension mortality in a broad spectrum of patients with cardiovascular disease,” Journal of the American College of Cardiology, vol. 53, no. 7, pp. 582–588, 2009. [21] T. L. Goodfriend and D. A. Calhoun, “Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy,” Hypertension, vol. 43, no. 3, pp. 518–524, 2004. [22] D. A. Calhoun, M. K. Nishizaka, M. A. Zaman, and S. M. Harding, “Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea,” Chest, vol. 125, no. 1, pp. 112–117, 2004. [23] C. Tsiouﬁs, K. Thomopoulos, K. Dimitriadis et al., “The incremental eﬀect of obstructive sleep apnoea syndrome on arterial stiﬀness in newly diagnosed essential hypertensive subjects,” Journal of Hypertension, vol. 25, no. 1, pp. 141–146, 2007. [24] J. E. Dimsdale, T. Coy, M. G. Ziegler, S. Ancoli-Israel, and J. Clausen, “The eﬀect of sleep apnea on plasma and urinary catecholamines,” Sleep, vol. 18, no. 5, pp. 377–381, 1995. [25] C. Thomopoulos, C. Tsiouﬁs, K. Dimitriadis et al., “Obstruc- tive sleep apnoea syndrome is associated with enhanced sub-clinical inﬂammation and asymmetric dimethyl-arginine levels in hypertensives,” Journal of Human Hypertension, vol. 23, no. 1, pp. 65–67, 2009. [26] A. G. Logan, S. M. Perlikowski, A. Mente et al., “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension,” Journal of Hypertension, vol. 19, no. 12, pp. 2271–2277, 2001. [27] P. Ruttanaumpawan, C. Nopmaneejumruslers, A. G. Logan, A. Lazarescu, I. Qian, and T. D. Bradley, “Association between refractory hypertension and obstructive sleep apnea,” Journal of Hypertension, vol. 27, no. 7, pp. 1439–1445, 2009. [28] S. C. Gonc¸alves, D. Martinez, M. Gus et al., “Obstructive sleep apnea and resistant hypertension: a case-control study,” Chest, vol. 132, no. 6, pp. 1858–1862, 2007. [29] M. A. Martı´nez-Garcı´a, R. G o´mez-Aldaravı´, T. Gil-Martı´nez, J. J. Soler-Catalun˜a, B. Berna´cer-Alpera, and P. Rom a´n-S a´nchez, “Sleep-disordered breathing in patients with diﬃcult-to- control hypertension,” Archivos de Bronconeumologia, vol. 42, no. 1, pp. 14–20, 2006. [30] M. N. Pratt-Ubunama, M. K. Nishizaka, R. L. Boedefeld, S. S. Coﬁeld, S. M. Harding, and D. A. Calhoun, “Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension,” Chest, vol. 131, no. 2, pp. 453–459, 2007. [31] A. G. Logan, R. Tkacova, S. M. Perlikowski et al., “Refractory hypertension and sleep apnoea: eﬀect of CPAP on blood pressure and baroreﬂex,” European Respiratory Journal, vol. 21, no. 2, pp. 241–247, 2003. [32] M. A. Martı´nez-Garcı´a, R. G o´mez-Aldaravı´, J. J. Soler- Catalun˜a, T. G. Martı´nez, B. Berna´cer-Alpera, and P. Rom a´n- S a´nchez, “Positive eﬀect of CPAP treatment on the control of diﬃcult-to-treat hypertension,” European Respiratory Journal, vol. 29, no. 5, pp. 951–957, 2007. [33] L. Lozano, J. L. Tovar, G. Sampol et al., “Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial,” Journal of Hypertension, vol. 28, pp. 2161–2168, 2010. [34] T. A. Dernaika, G. T. Kinasewitz, and M. M. Tawk, “Eﬀects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea,” Journal of Clinical Sleep Medicine, vol. 5, no. 2, pp. 103– 107, 2009. [35] F. Campos-Rodriguez, A. Grilo-Reina, J. Perez-Ronchel et al., “Eﬀect of continuous positive airway pressure on ambulatory 5 BP in patients with sleep apnea and hypertension: a placebo- controlled trial,” Chest, vol. 129, no. 6, pp. 1459–1467, 2006. [36] F. Campos-Rodriguez, J. Perez-Ronchel, A. Grilo-Reina, J. Lima-Alvarez, M. A. Benitez, and C. Almeida-Gonzalez, “Long-term eﬀect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea,” Chest, vol. 132, no. 6, pp. 1847–1852, 2007. [37] K. Gaddam, E. Pimenta, S. J. Thomas et al., “Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report,” Journal of Human Hypertension, vol. 24, pp. 532–537, 2009.